Digital Therapeutics Market Size, Share & Trends Report

Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity), By End Use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2025 - 2030

  • Report ID: GVR-1-68038-768-1
  • Number of Report Pages: 120
  • Format: PDF
  • Historical Range: 2018 - 2024
  • Forecast Period: 2025 - 2030 
  • Industry: Healthcare

Market Segmentation

  • Digital Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Patients
    • Providers
    • Payers
    • Employers
    • Others
  • Digital Therapeutics End Use Outlook (Revenue, USD Million, 2018 - 2030)
    • Diabetes
    • Obesity
    • CVD
    • Respiratory Diseases
    • Smoking Cessation
    • CNS Diseases
    • Others
  • Digital Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America digital therapeutics market, by application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • North America digital therapeutics market, by end use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • U.S.
        • U.S. digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • U.S. digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Canada
        • Canada digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Canada digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Mexico
        • Mexico digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Mexico digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Europe
      • Europe digital therapeutics market, by application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • Europe digital therapeutics market, by end use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • UK
        • UK digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • UK digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Germany
        • Germany digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Germany digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • France
        • France digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • France digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Italy
        • Italy digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Italy digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Spain
        • Spain digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Spain digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Denmark
        • Denmark digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Denmark digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Sweden
        • Sweden digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Sweden digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Norway
        • Norway digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Norway digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Rest of Europe
        • Rest of Europe digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Rest of Europe digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Asia Pacific
      • Asia Pacific digital therapeutics market, by application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • Asia Pacific digital therapeutics market, by end use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • China
        • China digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • China digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Japan
        • Japan digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Japan digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • India
        • India digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • India digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Australia
        • Australia digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Australia digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • South Korea
        • South Korea digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • South Korea digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Thailand
        • Thailand digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Thailand digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Rest of Asia Pacific
        • Rest of Asia Pacific digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Rest of Asia Pacific digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Latin America
      • Latin America digital therapeutics market, by application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • Latin America digital therapeutics market, by end use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • Brazil
        • Brazil digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Brazil digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Argentina
        • Argentina digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Argentina digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Rest of Latin America
        • Rest of Latin America digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Rest of Latin America digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
    • Middle East & Africa
      • Middle East & Africa digital therapeutics market, by application
        • Diabetes
        • Obesity
        • CVD
        • Respiratory Diseases
        • Smoking Cessation
        • CNS Diseases
        • Others
      • Middle East & Africa digital therapeutics market, by end use
        • Patients
        • Providers
        • Payers
        • Employers
        • Others
      • South Africa
        • South Africa digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • South Africa digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Saudi Arabia
        • Saudi Arabia digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Saudi Arabia digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • UAE
        • UAE digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • UAE digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Kuwait
        • Kuwait digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Kuwait digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa digital therapeutics market, by application
          • Diabetes
          • Obesity
          • CVD
          • Respiratory Diseases
          • Smoking Cessation
          • CNS Diseases
          • Others
        • Rest of Middle East & Africa digital therapeutics market, by end use
          • Patients
          • Providers
          • Payers
          • Employers
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon